|
References |
(1) |
Okazaki T, Kondo T, Kitano T, Tashima M: Diversity and complexity of ceramide signalling in apoptosis. Cell Signal. 10, 685-692, 1998
|
|
(2) |
Obeid LM, Hannun YA: Ceramide, stress, and a "LAG" in aging. Sci Aging Knowledge Environ. PE27, 2003 |
|
(3) |
Spiegel S, Milstien S: Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol. 4, 397-407, 2003 |
|
(4) |
五十嵐靖之: 概説 新しい生理活性脂質スフィンゴシン1−リン酸とその受容体研究の流れと今後の課題. 蛋白質 核酸 酵素, 47, 476-479, 2002 |
|
(5) |
Perry DK, Kolesnick RN: Ceramide and sphingosine 1-phosphate in anti-cancer therapies. Cancer Treat Res. 115, 345-354, 2003 |
|
(6) |
Cuvillier O, Pirianov G, Kleuser B, Vanek PG, Coso OA, Gutkind S, Spiegel S: Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature. 381, 800-803, 1996 |
|
(7) |
Kondo T, Kitano T, Iwai K, Watanabe M, Taguchi Y, Yabu T, Umehara H, Domae N, Uchiyama T, Okazaki T: Control of ceramide-induced apoptosis by IGF-1: involvement of PI-3 kinase, caspase-3 and catalase. Cell Death Differ. 9, 682-692, 2002 |
|
(8) |
近藤忠一, 岡崎俊朗: 生死におけるセラミド, PI-3キナーゼのクロストーク. 蛋白質 核酸 酵素, 47, 442-448, 2002 |
|
(9) |
岡崎俊朗, 伊東 信: 概説 セラミド・シグナル機構. 蛋白質 核酸 酵素, 47, 438-441, 2002 |
|
(10) |
Gulbins E, Kolesnick R: Raft ceramide in molecular medicine. Oncogene, 22, 7070-7077, 2003 |
|
|
|
|
|